# TransEnterix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/transenterix

- Industry: Medical Devices & Equipment
- Headquarters: Morrisville, US
- Website: www.transenterix.com
- Total disclosed funding: $76M
- Latest round: Series B (Oct 5, 2009)
- Investors on record: 6

## About

TransEnterix Inc. is focused on enhancing surgical outcomes through advanced robotic surgical systems designed to improve precision and control in operating rooms.TransEnterix Inc. develops robotic-assisted surgical solutions, founded in 2006 in Morrisville, US. The company raised USD 15 mn in a Series B funding round in December 2011. The company is led by CEO Anthony Fernando, with Bill Starling as the founder.TransEnterix specializes in advanced robotic surgery systems, notably the Senhance® Surgical System, which incorporates the Intelligent Surgical Unit™ (ISU™) for real-time insights. Their product line includes a variety of reusable surgical instruments designed to optimize efficiency and enhance surgical outcomes, serving hospitals and surgical centers across North America, Europe, and select regions in Asia.In the most recent year, 2023, TransEnterix recorded a revenue of USD 8.577 mn and an EBITDA of USD -76.221 mn, reflecting its financial performance in the medical technology sector.TransEnterix plans to utilize its recent funding to further enhance its product offerings and expand into new geographic markets. They aim to introduce new features for the Senhance® Surgical System and are targeting expansion in Asia and Europe by 2025, bolstered by the USD 15 mn raised in the Series B round.

## Funding rounds

- Series B, Oct 5, 2009, $55M — Intersouth Partners, Quaker Partners Management, Parish Capital Advisors, SV Health Investors, Aisling Capital, Synergy Life Science Partners
- Series A, Dec 31, 2007, $21M — Parish Capital Advisors, SV Health Investors, Synergy Life Science Partners

## Investors

- Parish Capital Advisors (https://capitalatlas.ai/funds/parish-capital-advisors) — Series A, Series B
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A, Series B
- Synergy Life Science Partners (https://capitalatlas.ai/funds/synergy-life-science-partners) — Series A, Series B
- Intersouth Partners (https://capitalatlas.ai/funds/intersouth-partners) — Series B
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series B
- Aisling Capital (https://capitalatlas.ai/funds/aisling-capital) — Series B